nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Glutamine—TGM2—Alpha9 beta1 integrin signaling events—VEGFC—sarcoma	0.0177	0.112	CbGpPWpGaD
L-Glutamine—F13A1—Alpha9 beta1 integrin signaling events—VEGFC—sarcoma	0.0119	0.0756	CbGpPWpGaD
L-Glutamine—TGM2—Beta1 integrin cell surface interactions—COL18A1—sarcoma	0.0107	0.068	CbGpPWpGaD
L-Glutamine—TGM7—testis—sarcoma	0.0104	0.0187	CbGeAlD
L-Glutamine—TGM2—endothelium—sarcoma	0.00914	0.0164	CbGeAlD
L-Glutamine—NADSYN1—mammary gland—sarcoma	0.00862	0.0154	CbGeAlD
L-Glutamine—F13A1—Beta1 integrin cell surface interactions—COL18A1—sarcoma	0.00724	0.0459	CbGpPWpGaD
L-Glutamine—TGM5—skin of body—sarcoma	0.00659	0.0118	CbGeAlD
L-Glutamine—F13A1—mammary gland—sarcoma	0.00612	0.0109	CbGeAlD
L-Glutamine—TGM4—testis—sarcoma	0.00599	0.0107	CbGeAlD
L-Glutamine—QARS—mammary gland—sarcoma	0.00581	0.0104	CbGeAlD
L-Glutamine—TGM3—hematopoietic system—sarcoma	0.00574	0.0103	CbGeAlD
L-Glutamine—PPAT—Fluoropyrimidine Activity—SMUG1—sarcoma	0.00537	0.0341	CbGpPWpGaD
L-Glutamine—TGM1—skin of body—sarcoma	0.00533	0.00954	CbGeAlD
L-Glutamine—NADSYN1—hematopoietic system—sarcoma	0.00525	0.0094	CbGeAlD
L-Glutamine—GLS2—hematopoietic system—sarcoma	0.00525	0.0094	CbGeAlD
L-Glutamine—GLS—embryo—sarcoma	0.00509	0.0091	CbGeAlD
L-Glutamine—CCBL1—seminal vesicle—sarcoma	0.00507	0.00908	CbGeAlD
L-Glutamine—TGM2—embryo—sarcoma	0.00503	0.009	CbGeAlD
L-Glutamine—TGM3—skin of body—sarcoma	0.00499	0.00894	CbGeAlD
L-Glutamine—CTPS1—myometrium—sarcoma	0.00492	0.00881	CbGeAlD
L-Glutamine—GMPS—myometrium—sarcoma	0.00492	0.00881	CbGeAlD
L-Glutamine—PFAS—myometrium—sarcoma	0.00484	0.00865	CbGeAlD
L-Glutamine—GFPT2—myometrium—sarcoma	0.00484	0.00865	CbGeAlD
L-Glutamine—GATB—hematopoietic system—sarcoma	0.00482	0.00863	CbGeAlD
L-Glutamine—F13A1—Platelet degranulation—VEGFC—sarcoma	0.0047	0.0298	CbGpPWpGaD
L-Glutamine—TGM1—cardiac atrium—sarcoma	0.00465	0.00833	CbGeAlD
L-Glutamine—GFPT2—embryo—sarcoma	0.00465	0.00832	CbGeAlD
L-Glutamine—TGM2—Alpha9 beta1 integrin signaling events—SRC—sarcoma	0.00461	0.0292	CbGpPWpGaD
L-Glutamine—SLC1A5—mammary gland—sarcoma	0.0046	0.00824	CbGeAlD
L-Glutamine—GLS—hematopoietic system—sarcoma	0.00454	0.00812	CbGeAlD
L-Glutamine—TGM2—hematopoietic system—sarcoma	0.00449	0.00804	CbGeAlD
L-Glutamine—TGM2—Alpha9 beta1 integrin signaling events—VEGFA—sarcoma	0.00449	0.0285	CbGpPWpGaD
L-Glutamine—F13A1—Response to elevated platelet cytosolic Ca2+—VEGFC—sarcoma	0.00448	0.0284	CbGpPWpGaD
L-Glutamine—CTPS1—seminal vesicle—sarcoma	0.00445	0.00796	CbGeAlD
L-Glutamine—GLS—connective tissue—sarcoma	0.00437	0.00782	CbGeAlD
L-Glutamine—PFAS—seminal vesicle—sarcoma	0.00437	0.00782	CbGeAlD
L-Glutamine—GFPT2—seminal vesicle—sarcoma	0.00437	0.00782	CbGeAlD
L-Glutamine—F13A1—myometrium—sarcoma	0.00434	0.00777	CbGeAlD
L-Glutamine—TGM2—connective tissue—sarcoma	0.00432	0.00774	CbGeAlD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—NPM1—sarcoma	0.00432	0.0274	CbGpPWpGaD
L-Glutamine—GMPS—hematopoietic system—sarcoma	0.00423	0.00757	CbGeAlD
L-Glutamine—CTPS1—hematopoietic system—sarcoma	0.00423	0.00757	CbGeAlD
L-Glutamine—PFAS—hematopoietic system—sarcoma	0.00415	0.00743	CbGeAlD
L-Glutamine—GFPT2—hematopoietic system—sarcoma	0.00415	0.00743	CbGeAlD
L-Glutamine—SLC7A8—mammary gland—sarcoma	0.00414	0.00742	CbGeAlD
L-Glutamine—QARS—myometrium—sarcoma	0.00412	0.00738	CbGeAlD
L-Glutamine—GMPS—connective tissue—sarcoma	0.00407	0.00729	CbGeAlD
L-Glutamine—TGM3—lymphoid tissue—sarcoma	0.00404	0.00724	CbGeAlD
L-Glutamine—QARS—embryo—sarcoma	0.00397	0.0071	CbGeAlD
L-Glutamine—TGM2—smooth muscle tissue—sarcoma	0.00395	0.00708	CbGeAlD
L-Glutamine—TGM5—liver—sarcoma	0.00393	0.00703	CbGeAlD
L-Glutamine—F13A1—seminal vesicle—sarcoma	0.00392	0.00702	CbGeAlD
L-Glutamine—TGM2—skin of body—sarcoma	0.0039	0.00699	CbGeAlD
L-Glutamine—CAD—myometrium—sarcoma	0.0038	0.00681	CbGeAlD
L-Glutamine—F13A1—hematopoietic system—sarcoma	0.00373	0.00667	CbGeAlD
L-Glutamine—QARS—seminal vesicle—sarcoma	0.00373	0.00667	CbGeAlD
L-Glutamine—NADSYN1—lymphoid tissue—sarcoma	0.0037	0.00662	CbGeAlD
L-Glutamine—GLS2—lymphoid tissue—sarcoma	0.0037	0.00662	CbGeAlD
L-Glutamine—GATB—cardiac atrium—sarcoma	0.00366	0.00655	CbGeAlD
L-Glutamine—CAD—embryo—sarcoma	0.00366	0.00655	CbGeAlD
L-Glutamine—GFPT2—smooth muscle tissue—sarcoma	0.00366	0.00655	CbGeAlD
L-Glutamine—F13A1—connective tissue—sarcoma	0.00359	0.00642	CbGeAlD
L-Glutamine—QARS—hematopoietic system—sarcoma	0.00354	0.00634	CbGeAlD
L-Glutamine—PPAT—myometrium—sarcoma	0.00353	0.00631	CbGeAlD
L-Glutamine—CAD—seminal vesicle—sarcoma	0.00344	0.00615	CbGeAlD
L-Glutamine—TGM2—uterus—sarcoma	0.00339	0.00607	CbGeAlD
L-Glutamine—TGM1—testis—sarcoma	0.00336	0.00601	CbGeAlD
L-Glutamine—SLC38A3—testis—sarcoma	0.00328	0.00588	CbGeAlD
L-Glutamine—SLC1A5—myometrium—sarcoma	0.00327	0.00585	CbGeAlD
L-Glutamine—CAD—hematopoietic system—sarcoma	0.00327	0.00585	CbGeAlD
L-Glutamine—GLUL—mammary gland—sarcoma	0.00323	0.00577	CbGeAlD
L-Glutamine—GLS—lymphoid tissue—sarcoma	0.0032	0.00572	CbGeAlD
L-Glutamine—CTPS1—uterus—sarcoma	0.00319	0.00572	CbGeAlD
L-Glutamine—CCBL1—tendon—sarcoma	0.00319	0.00571	CbGeAlD
L-Glutamine—GATB—tendon—sarcoma	0.00319	0.00571	CbGeAlD
L-Glutamine—PPAT—seminal vesicle—sarcoma	0.00319	0.0057	CbGeAlD
L-Glutamine—TGM2—lymphoid tissue—sarcoma	0.00316	0.00566	CbGeAlD
L-Glutamine—PFAS—cardiac atrium—sarcoma	0.00315	0.00564	CbGeAlD
L-Glutamine—GFPT2—cardiac atrium—sarcoma	0.00315	0.00564	CbGeAlD
L-Glutamine—TGM3—testis—sarcoma	0.00315	0.00563	CbGeAlD
L-Glutamine—GFPT2—uterus—sarcoma	0.00314	0.00561	CbGeAlD
L-Glutamine—QARS—smooth muscle tissue—sarcoma	0.00312	0.00558	CbGeAlD
L-Glutamine—F13A1—Alpha9 beta1 integrin signaling events—SRC—sarcoma	0.00311	0.0197	CbGpPWpGaD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—TEK—sarcoma	0.0031	0.0197	CbGpPWpGaD
L-Glutamine—SLC38A3—liver—sarcoma	0.0031	0.00555	CbGeAlD
L-Glutamine—QARS—skin of body—sarcoma	0.00308	0.00551	CbGeAlD
L-Glutamine—F13A1—Alpha9 beta1 integrin signaling events—VEGFA—sarcoma	0.00303	0.0192	CbGpPWpGaD
L-Glutamine—GLS—tendon—sarcoma	0.003	0.00538	CbGeAlD
L-Glutamine—GMPS—lymphoid tissue—sarcoma	0.00298	0.00533	CbGeAlD
L-Glutamine—SLC1A5—seminal vesicle—sarcoma	0.00295	0.00528	CbGeAlD
L-Glutamine—GFPT2—lymphoid tissue—sarcoma	0.00292	0.00523	CbGeAlD
L-Glutamine—GLS—bone marrow—sarcoma	0.00291	0.00521	CbGeAlD
L-Glutamine—GLS2—testis—sarcoma	0.00288	0.00515	CbGeAlD
L-Glutamine—NADSYN1—testis—sarcoma	0.00288	0.00515	CbGeAlD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—ANGPT2—sarcoma	0.00284	0.018	CbGpPWpGaD
L-Glutamine—F13A1—cardiac atrium—sarcoma	0.00283	0.00506	CbGeAlD
L-Glutamine—F13A1—uterus—sarcoma	0.00281	0.00504	CbGeAlD
L-Glutamine—SLC1A5—hematopoietic system—sarcoma	0.0028	0.00502	CbGeAlD
L-Glutamine—ASNS—myometrium—sarcoma	0.0028	0.00502	CbGeAlD
L-Glutamine—GMPS—tendon—sarcoma	0.0028	0.00501	CbGeAlD
L-Glutamine—CTPS1—tendon—sarcoma	0.0028	0.00501	CbGeAlD
L-Glutamine—PFAS—tendon—sarcoma	0.00275	0.00492	CbGeAlD
L-Glutamine—GFPT2—tendon—sarcoma	0.00275	0.00492	CbGeAlD
L-Glutamine—NADSYN1—liver—sarcoma	0.00272	0.00487	CbGeAlD
L-Glutamine—GLS2—liver—sarcoma	0.00272	0.00487	CbGeAlD
L-Glutamine—GMPS—bone marrow—sarcoma	0.00271	0.00485	CbGeAlD
L-Glutamine—CTPS1—bone marrow—sarcoma	0.00271	0.00485	CbGeAlD
L-Glutamine—SLC1A5—connective tissue—sarcoma	0.0027	0.00483	CbGeAlD
L-Glutamine—QARS—cardiac atrium—sarcoma	0.00269	0.00481	CbGeAlD
L-Glutamine—QARS—uterus—sarcoma	0.00267	0.00479	CbGeAlD
L-Glutamine—PFAS—bone marrow—sarcoma	0.00266	0.00476	CbGeAlD
L-Glutamine—CCBL1—testis—sarcoma	0.00264	0.00473	CbGeAlD
L-Glutamine—GATB—testis—sarcoma	0.00264	0.00473	CbGeAlD
L-Glutamine—Sepsis—Mitoxantrone—sarcoma	0.00263	0.00927	CcSEcCtD
L-Glutamine—F13A1—lymphoid tissue—sarcoma	0.00262	0.00469	CbGeAlD
L-Glutamine—Anorectal discomfort—Epirubicin—sarcoma	0.00258	0.00911	CcSEcCtD
L-Glutamine—ASNS—seminal vesicle—sarcoma	0.00253	0.00453	CbGeAlD
L-Glutamine—GATB—liver—sarcoma	0.0025	0.00447	CbGeAlD
L-Glutamine—CCBL1—liver—sarcoma	0.0025	0.00447	CbGeAlD
L-Glutamine—QARS—lymphoid tissue—sarcoma	0.00249	0.00446	CbGeAlD
L-Glutamine—GLS—testis—sarcoma	0.00249	0.00445	CbGeAlD
L-Glutamine—SLC1A5—smooth muscle tissue—sarcoma	0.00247	0.00442	CbGeAlD
L-Glutamine—CAD—uterus—sarcoma	0.00247	0.00442	CbGeAlD
L-Glutamine—F13A1—tendon—sarcoma	0.00247	0.00441	CbGeAlD
L-Glutamine—TGM2—testis—sarcoma	0.00246	0.0044	CbGeAlD
L-Glutamine—SLC1A5—skin of body—sarcoma	0.00244	0.00436	CbGeAlD
L-Glutamine—TGM1—lymph node—sarcoma	0.00243	0.00436	CbGeAlD
L-Glutamine—Gastric ulcer—Epirubicin—sarcoma	0.00243	0.00857	CcSEcCtD
L-Glutamine—TGM2—Thromboxane A2 receptor signaling—SRC—sarcoma	0.00242	0.0153	CbGpPWpGaD
L-Glutamine—Candida infection—Etoposide—sarcoma	0.00241	0.00848	CcSEcCtD
L-Glutamine—Anorectal discomfort—Doxorubicin—sarcoma	0.00239	0.00843	CcSEcCtD
L-Glutamine—F13A1—bone marrow—sarcoma	0.00239	0.00427	CbGeAlD
L-Glutamine—Dehydration—Thiotepa—sarcoma	0.00237	0.00835	CcSEcCtD
L-Glutamine—GLS—liver—sarcoma	0.00235	0.00421	CbGeAlD
L-Glutamine—Enlargement abdomen—Epirubicin—sarcoma	0.00235	0.00828	CcSEcCtD
L-Glutamine—QARS—tendon—sarcoma	0.00234	0.00419	CbGeAlD
L-Glutamine—TGM2—liver—sarcoma	0.00233	0.00416	CbGeAlD
L-Glutamine—CTPS1—testis—sarcoma	0.00232	0.00415	CbGeAlD
L-Glutamine—GMPS—testis—sarcoma	0.00232	0.00415	CbGeAlD
L-Glutamine—GLUL—myometrium—sarcoma	0.00229	0.0041	CbGeAlD
L-Glutamine—GFPT2—testis—sarcoma	0.00228	0.00407	CbGeAlD
L-Glutamine—PFAS—testis—sarcoma	0.00228	0.00407	CbGeAlD
L-Glutamine—QARS—bone marrow—sarcoma	0.00227	0.00406	CbGeAlD
L-Glutamine—Gastric ulcer—Doxorubicin—sarcoma	0.00225	0.00793	CcSEcCtD
L-Glutamine—GLUL—embryo—sarcoma	0.0022	0.00394	CbGeAlD
L-Glutamine—SLC7A8—skin of body—sarcoma	0.0022	0.00393	CbGeAlD
L-Glutamine—CTPS1—liver—sarcoma	0.00219	0.00392	CbGeAlD
L-Glutamine—GMPS—liver—sarcoma	0.00219	0.00392	CbGeAlD
L-Glutamine—Sepsis—Etoposide—sarcoma	0.00219	0.00771	CcSEcCtD
L-Glutamine—Nail disorder—Epirubicin—sarcoma	0.00218	0.00768	CcSEcCtD
L-Glutamine—Enlargement abdomen—Doxorubicin—sarcoma	0.00217	0.00766	CcSEcCtD
L-Glutamine—CAD—tendon—sarcoma	0.00216	0.00387	CbGeAlD
L-Glutamine—PFAS—liver—sarcoma	0.00215	0.00385	CbGeAlD
L-Glutamine—GFPT2—liver—sarcoma	0.00215	0.00385	CbGeAlD
L-Glutamine—SLC1A5—cardiac atrium—sarcoma	0.00213	0.00381	CbGeAlD
L-Glutamine—ASNS—smooth muscle tissue—sarcoma	0.00212	0.00379	CbGeAlD
L-Glutamine—SLC1A5—uterus—sarcoma	0.00212	0.00379	CbGeAlD
L-Glutamine—TGM2—Thromboxane A2 receptor signaling—EGFR—sarcoma	0.00212	0.0134	CbGpPWpGaD
L-Glutamine—Dehydration—Vincristine—sarcoma	0.0021	0.00741	CcSEcCtD
L-Glutamine—CAD—bone marrow—sarcoma	0.00209	0.00375	CbGeAlD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—VEGFC—sarcoma	0.00209	0.0132	CbGpPWpGaD
L-Glutamine—NADSYN1—lymph node—sarcoma	0.00209	0.00373	CbGeAlD
L-Glutamine—GLS2—lymph node—sarcoma	0.00209	0.00373	CbGeAlD
L-Glutamine—TGM2—Beta1 integrin cell surface interactions—VEGFA—sarcoma	0.00206	0.0131	CbGpPWpGaD
L-Glutamine—Dehydration—Mitoxantrone—sarcoma	0.00205	0.00721	CcSEcCtD
L-Glutamine—F13A1—testis—sarcoma	0.00204	0.00365	CbGeAlD
L-Glutamine—Nail disorder—Doxorubicin—sarcoma	0.00202	0.00711	CcSEcCtD
L-Glutamine—PPAT—tendon—sarcoma	0.002	0.00359	CbGeAlD
L-Glutamine—SLC1A5—lymphoid tissue—sarcoma	0.00197	0.00353	CbGeAlD
L-Glutamine—GLUL—hematopoietic system—sarcoma	0.00197	0.00352	CbGeAlD
L-Glutamine—Laryngitis—Epirubicin—sarcoma	0.00196	0.00691	CcSEcCtD
L-Glutamine—PPAT—bone marrow—sarcoma	0.00194	0.00348	CbGeAlD
L-Glutamine—QARS—testis—sarcoma	0.00194	0.00347	CbGeAlD
L-Glutamine—F13A1—liver—sarcoma	0.00193	0.00345	CbGeAlD
L-Glutamine—CCBL1—lymph node—sarcoma	0.00191	0.00343	CbGeAlD
L-Glutamine—GATB—lymph node—sarcoma	0.00191	0.00343	CbGeAlD
L-Glutamine—GLUL—connective tissue—sarcoma	0.00189	0.00339	CbGeAlD
L-Glutamine—SLC1A5—tendon—sarcoma	0.00186	0.00332	CbGeAlD
L-Glutamine—Sweating increased—Mitoxantrone—sarcoma	0.00185	0.00653	CcSEcCtD
L-Glutamine—QARS—liver—sarcoma	0.00183	0.00328	CbGeAlD
L-Glutamine—Fungal infection—Epirubicin—sarcoma	0.00183	0.00645	CcSEcCtD
L-Glutamine—ASNS—cardiac atrium—sarcoma	0.00183	0.00327	CbGeAlD
L-Glutamine—ASNS—uterus—sarcoma	0.00182	0.00325	CbGeAlD
L-Glutamine—Laryngitis—Doxorubicin—sarcoma	0.00181	0.00639	CcSEcCtD
L-Glutamine—GLS—lymph node—sarcoma	0.0018	0.00323	CbGeAlD
L-Glutamine—SLC1A5—bone marrow—sarcoma	0.0018	0.00322	CbGeAlD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—PLCG1—sarcoma	0.00179	0.0114	CbGpPWpGaD
L-Glutamine—CAD—testis—sarcoma	0.00179	0.0032	CbGeAlD
L-Glutamine—Urinary tract disorder—Thiotepa—sarcoma	0.00174	0.00614	CcSEcCtD
L-Glutamine—Pharyngitis—Dactinomycin—sarcoma	0.00174	0.00612	CcSEcCtD
L-Glutamine—Depression—Vincristine—sarcoma	0.00174	0.00612	CcSEcCtD
L-Glutamine—GLUL—smooth muscle tissue—sarcoma	0.00173	0.0031	CbGeAlD
L-Glutamine—Rigors—Epirubicin—sarcoma	0.00173	0.0061	CcSEcCtD
L-Glutamine—Injection site pain—Epirubicin—sarcoma	0.00173	0.0061	CcSEcCtD
L-Glutamine—Urethral disorder—Thiotepa—sarcoma	0.00173	0.00609	CcSEcCtD
L-Glutamine—GLUL—skin of body—sarcoma	0.00171	0.00306	CbGeAlD
L-Glutamine—Neuropathy peripheral—Vincristine—sarcoma	0.00171	0.00602	CcSEcCtD
L-Glutamine—Fungal infection—Doxorubicin—sarcoma	0.00169	0.00597	CcSEcCtD
L-Glutamine—CAD—liver—sarcoma	0.00169	0.00303	CbGeAlD
L-Glutamine—GMPS—lymph node—sarcoma	0.00168	0.00301	CbGeAlD
L-Glutamine—CTPS1—lymph node—sarcoma	0.00168	0.00301	CbGeAlD
L-Glutamine—SLC7A8—tendon—sarcoma	0.00167	0.00299	CbGeAlD
L-Glutamine—PPAT—testis—sarcoma	0.00166	0.00297	CbGeAlD
L-Glutamine—GFPT2—lymph node—sarcoma	0.00165	0.00295	CbGeAlD
L-Glutamine—PFAS—lymph node—sarcoma	0.00165	0.00295	CbGeAlD
L-Glutamine—Breast pain—Epirubicin—sarcoma	0.00162	0.00571	CcSEcCtD
L-Glutamine—Rigors—Doxorubicin—sarcoma	0.0016	0.00565	CcSEcCtD
L-Glutamine—Injection site pain—Doxorubicin—sarcoma	0.0016	0.00565	CcSEcCtD
L-Glutamine—Angiopathy—Thiotepa—sarcoma	0.0016	0.00564	CcSEcCtD
L-Glutamine—ASNS—tendon—sarcoma	0.00159	0.00285	CbGeAlD
L-Glutamine—Chills—Thiotepa—sarcoma	0.00158	0.00557	CcSEcCtD
L-Glutamine—PPAT—liver—sarcoma	0.00157	0.00281	CbGeAlD
L-Glutamine—Chills—Dactinomycin—sarcoma	0.00157	0.00553	CcSEcCtD
L-Glutamine—Viral infection—Epirubicin—sarcoma	0.00156	0.00551	CcSEcCtD
L-Glutamine—Mental disorder—Thiotepa—sarcoma	0.00154	0.00544	CcSEcCtD
L-Glutamine—Urinary tract disorder—Vincristine—sarcoma	0.00154	0.00544	CcSEcCtD
L-Glutamine—ASNS—bone marrow—sarcoma	0.00154	0.00276	CbGeAlD
L-Glutamine—Sweating increased—Etoposide—sarcoma	0.00154	0.00543	CcSEcCtD
L-Glutamine—SLC1A5—testis—sarcoma	0.00154	0.00275	CbGeAlD
L-Glutamine—Malnutrition—Thiotepa—sarcoma	0.00153	0.00541	CcSEcCtD
L-Glutamine—Urethral disorder—Vincristine—sarcoma	0.00153	0.0054	CcSEcCtD
L-Glutamine—Rhinitis—Mitoxantrone—sarcoma	0.00153	0.00538	CcSEcCtD
L-Glutamine—Pharyngitis—Mitoxantrone—sarcoma	0.00151	0.00532	CcSEcCtD
L-Glutamine—SLC16A10—hematopoietic system—sarcoma	0.0015	0.00268	CbGeAlD
L-Glutamine—Breast pain—Doxorubicin—sarcoma	0.0015	0.00528	CcSEcCtD
L-Glutamine—GLUL—uterus—sarcoma	0.00148	0.00266	CbGeAlD
L-Glutamine—Back pain—Thiotepa—sarcoma	0.00148	0.00523	CcSEcCtD
L-Glutamine—F13A1—lymph node—sarcoma	0.00148	0.00265	CbGeAlD
L-Glutamine—F13A1—Hemostasis—TEK—sarcoma	0.00147	0.00929	CbGpPWpGaD
L-Glutamine—SLC1A5—liver—sarcoma	0.00145	0.0026	CbGeAlD
L-Glutamine—Viral infection—Doxorubicin—sarcoma	0.00145	0.0051	CcSEcCtD
L-Glutamine—PPAT—Fluoropyrimidine Activity—TP53—sarcoma	0.00143	0.00904	CbGpPWpGaD
L-Glutamine—Angiopathy—Vincristine—sarcoma	0.00142	0.005	CcSEcCtD
L-Glutamine—Ill-defined disorder—Dactinomycin—sarcoma	0.00141	0.00498	CcSEcCtD
L-Glutamine—QARS—lymph node—sarcoma	0.00141	0.00252	CbGeAlD
L-Glutamine—Injection site reaction—Epirubicin—sarcoma	0.0014	0.00495	CcSEcCtD
L-Glutamine—F13A1—Beta1 integrin cell surface interactions—VEGFA—sarcoma	0.00139	0.00884	CbGpPWpGaD
L-Glutamine—SLC7A8—testis—sarcoma	0.00138	0.00248	CbGeAlD
L-Glutamine—GLUL—lymphoid tissue—sarcoma	0.00138	0.00248	CbGeAlD
L-Glutamine—Neuropathy peripheral—Etoposide—sarcoma	0.00138	0.00487	CcSEcCtD
L-Glutamine—Malaise—Dactinomycin—sarcoma	0.00137	0.00484	CcSEcCtD
L-Glutamine—Mental disorder—Vincristine—sarcoma	0.00137	0.00483	CcSEcCtD
L-Glutamine—Chills—Mitoxantrone—sarcoma	0.00137	0.00481	CcSEcCtD
L-Glutamine—Candida infection—Epirubicin—sarcoma	0.00135	0.00476	CcSEcCtD
L-Glutamine—F13A1—Hemostasis—ANGPT2—sarcoma	0.00134	0.0085	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—FUS—sarcoma	0.00133	0.00844	CbGpPWpGaD
L-Glutamine—ASNS—testis—sarcoma	0.00132	0.00236	CbGeAlD
L-Glutamine—Back pain—Vincristine—sarcoma	0.00132	0.00464	CcSEcCtD
L-Glutamine—SLC7A8—liver—sarcoma	0.00131	0.00234	CbGeAlD
L-Glutamine—Arthralgia—Thiotepa—sarcoma	0.00131	0.0046	CcSEcCtD
L-Glutamine—Myalgia—Thiotepa—sarcoma	0.00131	0.0046	CcSEcCtD
L-Glutamine—GLUL—tendon—sarcoma	0.0013	0.00233	CbGeAlD
L-Glutamine—Injection site reaction—Doxorubicin—sarcoma	0.0013	0.00458	CcSEcCtD
L-Glutamine—CAD—lymph node—sarcoma	0.0013	0.00232	CbGeAlD
L-Glutamine—Myalgia—Dactinomycin—sarcoma	0.0013	0.00457	CcSEcCtD
L-Glutamine—Back pain—Mitoxantrone—sarcoma	0.00128	0.00452	CcSEcCtD
L-Glutamine—Discomfort—Dactinomycin—sarcoma	0.00128	0.00451	CcSEcCtD
L-Glutamine—GLUL—bone marrow—sarcoma	0.00126	0.00225	CbGeAlD
L-Glutamine—Urinary tract disorder—Etoposide—sarcoma	0.00125	0.00441	CcSEcCtD
L-Glutamine—Candida infection—Doxorubicin—sarcoma	0.00125	0.0044	CcSEcCtD
L-Glutamine—ASNS—liver—sarcoma	0.00125	0.00223	CbGeAlD
L-Glutamine—Infection—Thiotepa—sarcoma	0.00124	0.00438	CcSEcCtD
L-Glutamine—Oedema—Dactinomycin—sarcoma	0.00124	0.00438	CcSEcCtD
L-Glutamine—Urethral disorder—Etoposide—sarcoma	0.00124	0.00437	CcSEcCtD
L-Glutamine—Infection—Dactinomycin—sarcoma	0.00123	0.00435	CcSEcCtD
L-Glutamine—Ill-defined disorder—Mitoxantrone—sarcoma	0.00123	0.00433	CcSEcCtD
L-Glutamine—Sepsis—Epirubicin—sarcoma	0.00123	0.00432	CcSEcCtD
L-Glutamine—PPAT—lymph node—sarcoma	0.0012	0.00215	CbGeAlD
L-Glutamine—F13A1—Platelet degranulation—VEGFA—sarcoma	0.0012	0.00758	CbGpPWpGaD
L-Glutamine—Malaise—Mitoxantrone—sarcoma	0.00119	0.00421	CcSEcCtD
L-Glutamine—Hepatic function abnormal—Epirubicin—sarcoma	0.00117	0.00414	CcSEcCtD
L-Glutamine—Myalgia—Vincristine—sarcoma	0.00116	0.00408	CcSEcCtD
L-Glutamine—Angiopathy—Etoposide—sarcoma	0.00115	0.00405	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00114	0.00402	CcSEcCtD
L-Glutamine—F13A1—Response to elevated platelet cytosolic Ca2+—VEGFA—sarcoma	0.00114	0.00722	CbGpPWpGaD
L-Glutamine—Chills—Etoposide—sarcoma	0.00114	0.004	CcSEcCtD
L-Glutamine—Sepsis—Doxorubicin—sarcoma	0.00113	0.004	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00113	0.00399	CcSEcCtD
L-Glutamine—Chest pain—Mitoxantrone—sarcoma	0.00113	0.00398	CcSEcCtD
L-Glutamine—Arthralgia—Mitoxantrone—sarcoma	0.00113	0.00398	CcSEcCtD
L-Glutamine—Myalgia—Mitoxantrone—sarcoma	0.00113	0.00398	CcSEcCtD
L-Glutamine—SLC1A5—lymph node—sarcoma	0.00111	0.00199	CbGeAlD
L-Glutamine—Discomfort—Mitoxantrone—sarcoma	0.00111	0.00393	CcSEcCtD
L-Glutamine—Oedema—Vincristine—sarcoma	0.00111	0.00391	CcSEcCtD
L-Glutamine—Infection—Vincristine—sarcoma	0.0011	0.00389	CcSEcCtD
L-Glutamine—Hepatic function abnormal—Doxorubicin—sarcoma	0.00109	0.00383	CcSEcCtD
L-Glutamine—Oedema—Mitoxantrone—sarcoma	0.00108	0.00381	CcSEcCtD
L-Glutamine—Fatigue—Thiotepa—sarcoma	0.00108	0.00381	CcSEcCtD
L-Glutamine—GLUL—testis—sarcoma	0.00108	0.00193	CbGeAlD
L-Glutamine—F13A1—Hemostasis—VEGFC—sarcoma	0.00108	0.00682	CbGpPWpGaD
L-Glutamine—Infection—Mitoxantrone—sarcoma	0.00107	0.00379	CcSEcCtD
L-Glutamine—Hyperhidrosis—Vincristine—sarcoma	0.00107	0.00378	CcSEcCtD
L-Glutamine—Fatigue—Dactinomycin—sarcoma	0.00107	0.00378	CcSEcCtD
L-Glutamine—Pain—Thiotepa—sarcoma	0.00107	0.00377	CcSEcCtD
L-Glutamine—Constipation—Thiotepa—sarcoma	0.00107	0.00377	CcSEcCtD
L-Glutamine—Back pain—Etoposide—sarcoma	0.00107	0.00376	CcSEcCtD
L-Glutamine—Pain—Dactinomycin—sarcoma	0.00106	0.00375	CcSEcCtD
L-Glutamine—SLC16A10—lymphoid tissue—sarcoma	0.00106	0.00189	CbGeAlD
L-Glutamine—Hyperhidrosis—Mitoxantrone—sarcoma	0.00104	0.00368	CcSEcCtD
L-Glutamine—Feeling abnormal—Thiotepa—sarcoma	0.00103	0.00364	CcSEcCtD
L-Glutamine—Feeling abnormal—Dactinomycin—sarcoma	0.00102	0.00361	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Thiotepa—sarcoma	0.00102	0.00361	CcSEcCtD
L-Glutamine—Ill-defined disorder—Etoposide—sarcoma	0.00102	0.0036	CcSEcCtD
L-Glutamine—GLUL—liver—sarcoma	0.00102	0.00182	CbGeAlD
L-Glutamine—Gastrointestinal pain—Dactinomycin—sarcoma	0.00102	0.00358	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Vincristine—sarcoma	0.00101	0.00357	CcSEcCtD
L-Glutamine—Insomnia—Vincristine—sarcoma	0.001	0.00354	CcSEcCtD
L-Glutamine—SLC7A8—lymph node—sarcoma	0.001	0.0018	CbGeAlD
L-Glutamine—Malaise—Etoposide—sarcoma	0.000993	0.0035	CcSEcCtD
L-Glutamine—SLC16A10—tendon—sarcoma	0.000992	0.00178	CbGeAlD
L-Glutamine—Abdominal pain—Thiotepa—sarcoma	0.000989	0.00349	CcSEcCtD
L-Glutamine—Body temperature increased—Thiotepa—sarcoma	0.000989	0.00349	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000985	0.00347	CcSEcCtD
L-Glutamine—Abdominal pain—Dactinomycin—sarcoma	0.000982	0.00346	CcSEcCtD
L-Glutamine—Body temperature increased—Dactinomycin—sarcoma	0.000982	0.00346	CcSEcCtD
L-Glutamine—GLS2—Transmission across Chemical Synapses—CREB1—sarcoma	0.000964	0.00611	CbGpPWpGaD
L-Glutamine—GLS—Transmission across Chemical Synapses—CREB1—sarcoma	0.000964	0.00611	CbGpPWpGaD
L-Glutamine—Fatigue—Vincristine—sarcoma	0.000957	0.00337	CcSEcCtD
L-Glutamine—ASNS—lymph node—sarcoma	0.000956	0.00171	CbGeAlD
L-Glutamine—Dehydration—Epirubicin—sarcoma	0.000954	0.00336	CcSEcCtD
L-Glutamine—Constipation—Vincristine—sarcoma	0.000949	0.00335	CcSEcCtD
L-Glutamine—Pain—Vincristine—sarcoma	0.000949	0.00335	CcSEcCtD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—MYC—sarcoma	0.000944	0.00599	CbGpPWpGaD
L-Glutamine—Chest pain—Etoposide—sarcoma	0.000938	0.00331	CcSEcCtD
L-Glutamine—Fatigue—Mitoxantrone—sarcoma	0.000932	0.00329	CcSEcCtD
L-Glutamine—Discomfort—Etoposide—sarcoma	0.000927	0.00327	CcSEcCtD
L-Glutamine—Pain—Mitoxantrone—sarcoma	0.000924	0.00326	CcSEcCtD
L-Glutamine—Constipation—Mitoxantrone—sarcoma	0.000924	0.00326	CcSEcCtD
L-Glutamine—Hypersensitivity—Thiotepa—sarcoma	0.000922	0.00325	CcSEcCtD
L-Glutamine—Hypersensitivity—Dactinomycin—sarcoma	0.000915	0.00323	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Vincristine—sarcoma	0.000908	0.0032	CcSEcCtD
L-Glutamine—Asthenia—Thiotepa—sarcoma	0.000898	0.00317	CcSEcCtD
L-Glutamine—Infection—Etoposide—sarcoma	0.000893	0.00315	CcSEcCtD
L-Glutamine—Abdominal distension—Epirubicin—sarcoma	0.000892	0.00315	CcSEcCtD
L-Glutamine—Asthenia—Dactinomycin—sarcoma	0.000891	0.00314	CcSEcCtD
L-Glutamine—Feeling abnormal—Mitoxantrone—sarcoma	0.000891	0.00314	CcSEcCtD
L-Glutamine—Pruritus—Thiotepa—sarcoma	0.000885	0.00312	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000884	0.00312	CcSEcCtD
L-Glutamine—Dehydration—Doxorubicin—sarcoma	0.000882	0.00311	CcSEcCtD
L-Glutamine—Abdominal pain—Vincristine—sarcoma	0.000877	0.00309	CcSEcCtD
L-Glutamine—Body temperature increased—Vincristine—sarcoma	0.000877	0.00309	CcSEcCtD
L-Glutamine—Hyperhidrosis—Etoposide—sarcoma	0.000869	0.00306	CcSEcCtD
L-Glutamine—Pancreatitis—Epirubicin—sarcoma	0.000869	0.00306	CcSEcCtD
L-Glutamine—Abdominal pain—Mitoxantrone—sarcoma	0.000854	0.00301	CcSEcCtD
L-Glutamine—Body temperature increased—Mitoxantrone—sarcoma	0.000854	0.00301	CcSEcCtD
L-Glutamine—F13A1—Hemostasis—PLCG1—sarcoma	0.000845	0.00536	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—TEK—sarcoma	0.000842	0.00534	CbGpPWpGaD
L-Glutamine—Dizziness—Thiotepa—sarcoma	0.000828	0.00292	CcSEcCtD
L-Glutamine—Abdominal distension—Doxorubicin—sarcoma	0.000825	0.00291	CcSEcCtD
L-Glutamine—SLC16A10—testis—sarcoma	0.000821	0.00147	CbGeAlD
L-Glutamine—Hypersensitivity—Vincristine—sarcoma	0.000818	0.00288	CcSEcCtD
L-Glutamine—Pancreatitis—Doxorubicin—sarcoma	0.000804	0.00284	CcSEcCtD
L-Glutamine—GLS2—Transmission across Chemical Synapses—MDM2—sarcoma	0.000798	0.00506	CbGpPWpGaD
L-Glutamine—GLS—Transmission across Chemical Synapses—MDM2—sarcoma	0.000798	0.00506	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Mitoxantrone—sarcoma	0.000796	0.00281	CcSEcCtD
L-Glutamine—Asthenia—Vincristine—sarcoma	0.000796	0.00281	CcSEcCtD
L-Glutamine—Vomiting—Thiotepa—sarcoma	0.000796	0.00281	CcSEcCtD
L-Glutamine—Vomiting—Dactinomycin—sarcoma	0.00079	0.00279	CcSEcCtD
L-Glutamine—Rash—Thiotepa—sarcoma	0.000789	0.00278	CcSEcCtD
L-Glutamine—Dermatitis—Thiotepa—sarcoma	0.000788	0.00278	CcSEcCtD
L-Glutamine—Headache—Thiotepa—sarcoma	0.000784	0.00277	CcSEcCtD
L-Glutamine—Rash—Dactinomycin—sarcoma	0.000783	0.00276	CcSEcCtD
L-Glutamine—GLUL—lymph node—sarcoma	0.000781	0.0014	CbGeAlD
L-Glutamine—SLC16A10—liver—sarcoma	0.000776	0.00139	CbGeAlD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—TP53—sarcoma	0.000776	0.00492	CbGpPWpGaD
L-Glutamine—Asthenia—Mitoxantrone—sarcoma	0.000775	0.00273	CcSEcCtD
L-Glutamine—Fatigue—Etoposide—sarcoma	0.000775	0.00273	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Epirubicin—sarcoma	0.000775	0.00273	CcSEcCtD
L-Glutamine—SLC7A8—Hemostasis—ANGPT2—sarcoma	0.00077	0.00488	CbGpPWpGaD
L-Glutamine—Constipation—Etoposide—sarcoma	0.000769	0.00271	CcSEcCtD
L-Glutamine—Pain—Etoposide—sarcoma	0.000769	0.00271	CcSEcCtD
L-Glutamine—NADSYN1—Disease—TLE1—sarcoma	0.000745	0.00472	CbGpPWpGaD
L-Glutamine—Nausea—Thiotepa—sarcoma	0.000743	0.00262	CcSEcCtD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—JUN—sarcoma	0.000741	0.0047	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Etoposide—sarcoma	0.000741	0.00261	CcSEcCtD
L-Glutamine—GLS—Neuronal System—CREB1—sarcoma	0.000739	0.00468	CbGpPWpGaD
L-Glutamine—GLS2—Neuronal System—CREB1—sarcoma	0.000739	0.00468	CbGpPWpGaD
L-Glutamine—Nausea—Dactinomycin—sarcoma	0.000738	0.0026	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Etoposide—sarcoma	0.000735	0.00259	CcSEcCtD
L-Glutamine—Dizziness—Vincristine—sarcoma	0.000734	0.00259	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Doxorubicin—sarcoma	0.000717	0.00253	CcSEcCtD
L-Glutamine—Rhinitis—Epirubicin—sarcoma	0.000711	0.00251	CcSEcCtD
L-Glutamine—Body temperature increased—Etoposide—sarcoma	0.000711	0.00251	CcSEcCtD
L-Glutamine—Abdominal pain—Etoposide—sarcoma	0.000711	0.00251	CcSEcCtD
L-Glutamine—Vomiting—Vincristine—sarcoma	0.000706	0.00249	CcSEcCtD
L-Glutamine—Pharyngitis—Epirubicin—sarcoma	0.000704	0.00248	CcSEcCtD
L-Glutamine—Urinary tract disorder—Epirubicin—sarcoma	0.0007	0.00247	CcSEcCtD
L-Glutamine—Rash—Vincristine—sarcoma	0.0007	0.00247	CcSEcCtD
L-Glutamine—Dermatitis—Vincristine—sarcoma	0.000699	0.00247	CcSEcCtD
L-Glutamine—Urethral disorder—Epirubicin—sarcoma	0.000695	0.00245	CcSEcCtD
L-Glutamine—Headache—Vincristine—sarcoma	0.000695	0.00245	CcSEcCtD
L-Glutamine—Vomiting—Mitoxantrone—sarcoma	0.000687	0.00242	CcSEcCtD
L-Glutamine—Rash—Mitoxantrone—sarcoma	0.000681	0.0024	CcSEcCtD
L-Glutamine—Dermatitis—Mitoxantrone—sarcoma	0.000681	0.0024	CcSEcCtD
L-Glutamine—Headache—Mitoxantrone—sarcoma	0.000677	0.00239	CcSEcCtD
L-Glutamine—NADSYN1—Disease—NPM1—sarcoma	0.000672	0.00426	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Etoposide—sarcoma	0.000662	0.00234	CcSEcCtD
L-Glutamine—Nausea—Vincristine—sarcoma	0.000659	0.00232	CcSEcCtD
L-Glutamine—Rhinitis—Doxorubicin—sarcoma	0.000658	0.00232	CcSEcCtD
L-Glutamine—Pharyngitis—Doxorubicin—sarcoma	0.000651	0.0023	CcSEcCtD
L-Glutamine—CCBL1—Disease—TLE1—sarcoma	0.000651	0.00413	CbGpPWpGaD
L-Glutamine—Urinary tract disorder—Doxorubicin—sarcoma	0.000648	0.00229	CcSEcCtD
L-Glutamine—Asthenia—Etoposide—sarcoma	0.000645	0.00227	CcSEcCtD
L-Glutamine—Angiopathy—Epirubicin—sarcoma	0.000644	0.00227	CcSEcCtD
L-Glutamine—Urethral disorder—Doxorubicin—sarcoma	0.000643	0.00227	CcSEcCtD
L-Glutamine—Nausea—Mitoxantrone—sarcoma	0.000642	0.00226	CcSEcCtD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—NRAS—sarcoma	0.00064	0.00406	CbGpPWpGaD
L-Glutamine—Chills—Epirubicin—sarcoma	0.000636	0.00224	CcSEcCtD
L-Glutamine—Pruritus—Etoposide—sarcoma	0.000636	0.00224	CcSEcCtD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—IL2—sarcoma	0.000624	0.00396	CbGpPWpGaD
L-Glutamine—Mental disorder—Epirubicin—sarcoma	0.000621	0.00219	CcSEcCtD
L-Glutamine—SLC7A8—Hemostasis—VEGFC—sarcoma	0.000618	0.00392	CbGpPWpGaD
L-Glutamine—Malnutrition—Epirubicin—sarcoma	0.000617	0.00218	CcSEcCtD
L-Glutamine—GLS—Neuronal System—MDM2—sarcoma	0.000611	0.00388	CbGpPWpGaD
L-Glutamine—GLS2—Neuronal System—MDM2—sarcoma	0.000611	0.00388	CbGpPWpGaD
L-Glutamine—Flatulence—Epirubicin—sarcoma	0.000608	0.00215	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—ENO2—sarcoma	0.000598	0.00379	CbGpPWpGaD
L-Glutamine—Back pain—Epirubicin—sarcoma	0.000597	0.00211	CcSEcCtD
L-Glutamine—Angiopathy—Doxorubicin—sarcoma	0.000595	0.0021	CcSEcCtD
L-Glutamine—SLC16A10—lymph node—sarcoma	0.000595	0.00107	CbGeAlD
L-Glutamine—Dizziness—Etoposide—sarcoma	0.000594	0.0021	CcSEcCtD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—SRC—sarcoma	0.000594	0.00377	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—HBA1—sarcoma	0.000594	0.00377	CbGpPWpGaD
L-Glutamine—Chills—Doxorubicin—sarcoma	0.000589	0.00208	CcSEcCtD
L-Glutamine—CCBL1—Disease—NPM1—sarcoma	0.000587	0.00372	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—ENO2—sarcoma	0.000582	0.00369	CbGpPWpGaD
L-Glutamine—Mental disorder—Doxorubicin—sarcoma	0.000575	0.00203	CcSEcCtD
L-Glutamine—Ill-defined disorder—Epirubicin—sarcoma	0.000573	0.00202	CcSEcCtD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—NRAS—sarcoma	0.000572	0.00363	CbGpPWpGaD
L-Glutamine—Vomiting—Etoposide—sarcoma	0.000572	0.00202	CcSEcCtD
L-Glutamine—Malnutrition—Doxorubicin—sarcoma	0.000571	0.00201	CcSEcCtD
L-Glutamine—Rash—Etoposide—sarcoma	0.000567	0.002	CcSEcCtD
L-Glutamine—Dermatitis—Etoposide—sarcoma	0.000566	0.002	CcSEcCtD
L-Glutamine—Headache—Etoposide—sarcoma	0.000563	0.00199	CcSEcCtD
L-Glutamine—Flatulence—Doxorubicin—sarcoma	0.000563	0.00199	CcSEcCtD
L-Glutamine—Malaise—Epirubicin—sarcoma	0.000557	0.00196	CcSEcCtD
L-Glutamine—GLUL—Transmission across Chemical Synapses—CREB1—sarcoma	0.000554	0.00351	CbGpPWpGaD
L-Glutamine—Back pain—Doxorubicin—sarcoma	0.000553	0.00195	CcSEcCtD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—KRAS—sarcoma	0.00055	0.00349	CbGpPWpGaD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—SRC—sarcoma	0.000544	0.00345	CbGpPWpGaD
L-Glutamine—Nausea—Etoposide—sarcoma	0.000534	0.00188	CcSEcCtD
L-Glutamine—GMPS—Metabolism—ENO2—sarcoma	0.000533	0.00338	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—ENO2—sarcoma	0.000533	0.00338	CbGpPWpGaD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—VEGFA—sarcoma	0.00053	0.00336	CbGpPWpGaD
L-Glutamine—Ill-defined disorder—Doxorubicin—sarcoma	0.00053	0.00187	CcSEcCtD
L-Glutamine—GMPS—Metabolism—HBA1—sarcoma	0.00053	0.00336	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—HBA1—sarcoma	0.00053	0.00336	CbGpPWpGaD
L-Glutamine—Myalgia—Epirubicin—sarcoma	0.000526	0.00185	CcSEcCtD
L-Glutamine—Arthralgia—Epirubicin—sarcoma	0.000526	0.00185	CcSEcCtD
L-Glutamine—Chest pain—Epirubicin—sarcoma	0.000526	0.00185	CcSEcCtD
L-Glutamine—Discomfort—Epirubicin—sarcoma	0.000519	0.00183	CcSEcCtD
L-Glutamine—Malaise—Doxorubicin—sarcoma	0.000515	0.00182	CcSEcCtD
L-Glutamine—Dry mouth—Epirubicin—sarcoma	0.000514	0.00181	CcSEcCtD
L-Glutamine—CCBL1—Disease—ENO2—sarcoma	0.000509	0.00323	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PLCG1—sarcoma	0.000507	0.00322	CbGpPWpGaD
L-Glutamine—Oedema—Epirubicin—sarcoma	0.000504	0.00178	CcSEcCtD
L-Glutamine—Infection—Epirubicin—sarcoma	0.000501	0.00177	CcSEcCtD
L-Glutamine—NADSYN1—Disease—PLCG1—sarcoma	0.000494	0.00313	CbGpPWpGaD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—KRAS—sarcoma	0.000492	0.00312	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—ENO2—sarcoma	0.000487	0.00309	CbGpPWpGaD
L-Glutamine—Hyperhidrosis—Epirubicin—sarcoma	0.000487	0.00172	CcSEcCtD
L-Glutamine—Chest pain—Doxorubicin—sarcoma	0.000486	0.00172	CcSEcCtD
L-Glutamine—Arthralgia—Doxorubicin—sarcoma	0.000486	0.00172	CcSEcCtD
L-Glutamine—Myalgia—Doxorubicin—sarcoma	0.000486	0.00172	CcSEcCtD
L-Glutamine—SLC7A8—Hemostasis—PLCG1—sarcoma	0.000485	0.00308	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—HBA1—sarcoma	0.000484	0.00307	CbGpPWpGaD
L-Glutamine—Discomfort—Doxorubicin—sarcoma	0.000481	0.00169	CcSEcCtD
L-Glutamine—Dry mouth—Doxorubicin—sarcoma	0.000476	0.00168	CcSEcCtD
L-Glutamine—NADSYN1—Disease—CXCR4—sarcoma	0.000474	0.00301	CbGpPWpGaD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—HRAS—sarcoma	0.000468	0.00297	CbGpPWpGaD
L-Glutamine—Oedema—Doxorubicin—sarcoma	0.000466	0.00164	CcSEcCtD
L-Glutamine—Infection—Doxorubicin—sarcoma	0.000463	0.00163	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000459	0.00162	CcSEcCtD
L-Glutamine—GLUL—Transmission across Chemical Synapses—MDM2—sarcoma	0.000458	0.00291	CbGpPWpGaD
L-Glutamine—Insomnia—Epirubicin—sarcoma	0.000456	0.00161	CcSEcCtD
L-Glutamine—GMPS—Metabolism—PLCG1—sarcoma	0.000452	0.00287	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PLCG1—sarcoma	0.000452	0.00287	CbGpPWpGaD
L-Glutamine—Hyperhidrosis—Doxorubicin—sarcoma	0.000451	0.00159	CcSEcCtD
L-Glutamine—GLS2—Transmission across Chemical Synapses—HRAS—sarcoma	0.000438	0.00278	CbGpPWpGaD
L-Glutamine—GLS—Transmission across Chemical Synapses—HRAS—sarcoma	0.000438	0.00278	CbGpPWpGaD
L-Glutamine—Fatigue—Epirubicin—sarcoma	0.000434	0.00153	CcSEcCtD
L-Glutamine—CCBL1—Disease—PLCG1—sarcoma	0.000432	0.00274	CbGpPWpGaD
L-Glutamine—Constipation—Epirubicin—sarcoma	0.000431	0.00152	CcSEcCtD
L-Glutamine—Pain—Epirubicin—sarcoma	0.000431	0.00152	CcSEcCtD
L-Glutamine—CCBL1—Metabolism—ENO2—sarcoma	0.000426	0.0027	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—ENO2—sarcoma	0.000426	0.0027	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—ENO2—sarcoma	0.000426	0.0027	CbGpPWpGaD
L-Glutamine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000425	0.0015	CcSEcCtD
L-Glutamine—GLUL—Neuronal System—CREB1—sarcoma	0.000424	0.00269	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—HBA1—sarcoma	0.000423	0.00268	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—HBA1—sarcoma	0.000423	0.00268	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—HBA1—sarcoma	0.000423	0.00268	CbGpPWpGaD
L-Glutamine—Insomnia—Doxorubicin—sarcoma	0.000422	0.00149	CcSEcCtD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—HRAS—sarcoma	0.000418	0.00265	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Epirubicin—sarcoma	0.000415	0.00146	CcSEcCtD
L-Glutamine—CCBL1—Disease—CXCR4—sarcoma	0.000415	0.00263	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PLCG1—sarcoma	0.000414	0.00262	CbGpPWpGaD
L-Glutamine—Gastrointestinal pain—Epirubicin—sarcoma	0.000412	0.00145	CcSEcCtD
L-Glutamine—Fatigue—Doxorubicin—sarcoma	0.000402	0.00142	CcSEcCtD
L-Glutamine—Constipation—Doxorubicin—sarcoma	0.000399	0.00141	CcSEcCtD
L-Glutamine—Pain—Doxorubicin—sarcoma	0.000399	0.00141	CcSEcCtD
L-Glutamine—Abdominal pain—Epirubicin—sarcoma	0.000398	0.0014	CcSEcCtD
L-Glutamine—Body temperature increased—Epirubicin—sarcoma	0.000398	0.0014	CcSEcCtD
L-Glutamine—Feeling abnormal—Doxorubicin—sarcoma	0.000384	0.00136	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000381	0.00134	CcSEcCtD
L-Glutamine—Hypersensitivity—Epirubicin—sarcoma	0.000371	0.00131	CcSEcCtD
L-Glutamine—Abdominal pain—Doxorubicin—sarcoma	0.000369	0.0013	CcSEcCtD
L-Glutamine—Body temperature increased—Doxorubicin—sarcoma	0.000369	0.0013	CcSEcCtD
L-Glutamine—Asthenia—Epirubicin—sarcoma	0.000362	0.00128	CcSEcCtD
L-Glutamine—GLS—Metabolism—PLCG1—sarcoma	0.000361	0.00229	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PLCG1—sarcoma	0.000361	0.00229	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PLCG1—sarcoma	0.000361	0.00229	CbGpPWpGaD
L-Glutamine—GFPT2—Metabolism of proteins—MMP2—sarcoma	0.000357	0.00227	CbGpPWpGaD
L-Glutamine—Pruritus—Epirubicin—sarcoma	0.000357	0.00126	CcSEcCtD
L-Glutamine—GLUL—Neuronal System—MDM2—sarcoma	0.000351	0.00223	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—FOXO1—sarcoma	0.00035	0.00222	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PDGFRB—sarcoma	0.00035	0.00222	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PDGFRA—sarcoma	0.000344	0.00218	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Doxorubicin—sarcoma	0.000344	0.00121	CcSEcCtD
L-Glutamine—CAD—Metabolism—ENO2—sarcoma	0.000343	0.00218	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—HBA1—sarcoma	0.000341	0.00216	CbGpPWpGaD
L-Glutamine—GLS2—Neuronal System—HRAS—sarcoma	0.000335	0.00213	CbGpPWpGaD
L-Glutamine—GLS—Neuronal System—HRAS—sarcoma	0.000335	0.00213	CbGpPWpGaD
L-Glutamine—Asthenia—Doxorubicin—sarcoma	0.000335	0.00118	CcSEcCtD
L-Glutamine—Dizziness—Epirubicin—sarcoma	0.000333	0.00118	CcSEcCtD
L-Glutamine—Pruritus—Doxorubicin—sarcoma	0.00033	0.00116	CcSEcCtD
L-Glutamine—F13A1—Hemostasis—IL2—sarcoma	0.000322	0.00204	CbGpPWpGaD
L-Glutamine—Vomiting—Epirubicin—sarcoma	0.00032	0.00113	CcSEcCtD
L-Glutamine—Rash—Epirubicin—sarcoma	0.000318	0.00112	CcSEcCtD
L-Glutamine—Dermatitis—Epirubicin—sarcoma	0.000317	0.00112	CcSEcCtD
L-Glutamine—Headache—Epirubicin—sarcoma	0.000316	0.00111	CcSEcCtD
L-Glutamine—PPAT—Metabolism—ENO2—sarcoma	0.000314	0.00199	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—HBA1—sarcoma	0.000312	0.00198	CbGpPWpGaD
L-Glutamine—Dizziness—Doxorubicin—sarcoma	0.000308	0.00109	CcSEcCtD
L-Glutamine—CCBL1—Disease—FOXO1—sarcoma	0.000306	0.00194	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PDGFRB—sarcoma	0.000306	0.00194	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PDGFRA—sarcoma	0.000301	0.00191	CbGpPWpGaD
L-Glutamine—Nausea—Epirubicin—sarcoma	0.000299	0.00106	CcSEcCtD
L-Glutamine—Vomiting—Doxorubicin—sarcoma	0.000296	0.00105	CcSEcCtD
L-Glutamine—Rash—Doxorubicin—sarcoma	0.000294	0.00104	CcSEcCtD
L-Glutamine—Dermatitis—Doxorubicin—sarcoma	0.000294	0.00104	CcSEcCtD
L-Glutamine—Headache—Doxorubicin—sarcoma	0.000292	0.00103	CcSEcCtD
L-Glutamine—CAD—Metabolism—PLCG1—sarcoma	0.000291	0.00185	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—SRC—sarcoma	0.000281	0.00178	CbGpPWpGaD
L-Glutamine—Nausea—Doxorubicin—sarcoma	0.000277	0.000977	CcSEcCtD
L-Glutamine—GFPT2—Metabolism of proteins—CTNNB1—sarcoma	0.000274	0.00174	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—VEGFA—sarcoma	0.000273	0.00173	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—NRAS—sarcoma	0.00027	0.00171	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—KIT—sarcoma	0.000267	0.00169	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PLCG1—sarcoma	0.000266	0.00169	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CREB1—sarcoma	0.000254	0.00161	CbGpPWpGaD
L-Glutamine—GLUL—Transmission across Chemical Synapses—HRAS—sarcoma	0.000251	0.00159	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ENO2—sarcoma	0.000245	0.00155	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ENO2—sarcoma	0.000245	0.00155	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—HBA1—sarcoma	0.000243	0.00154	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—HBA1—sarcoma	0.000243	0.00154	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—KIT—sarcoma	0.000233	0.00148	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—KRAS—sarcoma	0.000232	0.00147	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CREB1—sarcoma	0.000222	0.00141	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MDM2—sarcoma	0.00021	0.00133	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PLCG1—sarcoma	0.000208	0.00132	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PLCG1—sarcoma	0.000208	0.00132	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—TP53—sarcoma	0.000206	0.00131	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—HRAS—sarcoma	0.000197	0.00125	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—MMP2—sarcoma	0.000193	0.00122	CbGpPWpGaD
L-Glutamine—GLUL—Neuronal System—HRAS—sarcoma	0.000193	0.00122	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—IL2—sarcoma	0.000185	0.00117	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MDM2—sarcoma	0.000184	0.00117	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CTNNB1—sarcoma	0.000181	0.00115	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—MYC—sarcoma	0.000173	0.0011	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—SRC—sarcoma	0.000164	0.00104	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—SRC—sarcoma	0.000161	0.00102	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CTNNB1—sarcoma	0.000159	0.00101	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—NRAS—sarcoma	0.000158	0.001	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—VEGFA—sarcoma	0.000157	0.000995	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—NRAS—sarcoma	0.000155	0.000983	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—CTNNB1—sarcoma	0.000148	0.000938	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MYC—sarcoma	0.000147	0.000932	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—EGFR—sarcoma	0.000144	0.000911	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—SRC—sarcoma	0.000143	0.000909	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—NRAS—sarcoma	0.000138	0.000874	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—KRAS—sarcoma	0.000136	0.000861	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—KRAS—sarcoma	0.000133	0.000846	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MYC—sarcoma	0.000128	0.000814	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—EGFR—sarcoma	0.000126	0.000796	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—KRAS—sarcoma	0.000119	0.000752	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—TP53—sarcoma	0.000119	0.000752	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—HRAS—sarcoma	0.000115	0.000732	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—HRAS—sarcoma	0.000113	0.000719	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—HRAS—sarcoma	0.000101	0.00064	CbGpPWpGaD
